Kangmei Pharma | 600518 - Loan Capital


Kangmei Pharma reported CNY68.57M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Avita Medical AUD 42.24M 1.25M Dec/2024
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Genomma Lab Internacional MXN 4.73B 67.16M Mar/2026
Hypermarcas BRL 8.11B 551.86M Dec/2025
Ionis Pharmaceuticals USD 1.91B 9M Mar/2026
IQVIA Holdings USD 13.99B 105M Mar/2026
Jiangsu Hengrui CNY 37.1M 6.2M Mar/2026
Kangmei Pharma CNY 68.57M 9.87M Mar/2026
Moderna USD 603M 7M Mar/2026
Organon & Co USD 8.55B 75M Mar/2026
Revvity USD 2.63B 836K Mar/2026
Sh Fosun Pharma CNY 15.95B 562.19M Mar/2026
Tectonic Therapeutic USD 43K 57K Dec/2025
Viatris USD 12.41B 67.1M Mar/2026
Wuxi Apptec CNY 1.82B 455.56M Mar/2026
Xeris Pharmaceuticals USD 221.22M 889K Mar/2026
Zz Pientze Pharmaceu CNY 182.29M 4.27M Mar/2026